{"id":"W4416087667","doi":"10.1016/j.jid.2025.09.221","title":"217 Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%: the 52-Week Phase 3 INTEGUMENT-OLE Trial in ≥2-year-olds","year":2025,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Roflumilast; Atopic dermatitis; Signs and symptoms; Clinical trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00100532,0.0007796925,0.001665922,0.0002541029,0.0003979433,0.0007358688,0.0004980922,0.0008098465,0.002698889],"category_scores_gemma":[0.0004760533,0.000364368,0.001707412,0.0002297855,0.0003217996,0.0004238242,0.0002153794,0.001487764,0.0004363968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004328604,"about_ca_system_score_gemma":0.0005618741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001680023,"about_ca_topic_score_gemma":0.004035511,"domain_scores_codex":[0.9997569,0.00008310008,0.00001919405,0.00003414563,0.00003371099,0.00007296972],"domain_scores_gemma":[0.9996977,0.00007020213,0.0000409314,0.00002044994,0.0000313952,0.0001395247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8339419,0.03508994,0.01707066,0.001320307,0.001961881,0.0004364776,0.0001520904,0.0003919552,0.02056413,0.00009516994,0.002330032,0.08664546],"study_design_scores_gemma":[0.4422468,0.441076,0.11028,0.000149182,0.001333595,0.0004283715,0.0001317711,0.0005407254,0.001688564,0.00007963576,0.002013352,0.00003203748],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943864,0.003469308,0.00007836651,0.0001267062,0.0001495866,0.0004166647,0.0003200384,0.00002384909,0.00102903],"genre_scores_gemma":[0.9938902,0.00252456,0.000251001,0.0004940379,0.0001874016,0.0003099732,0.0007019586,0.000007776689,0.001633126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002698889,"threshold_uncertainty_score":0.009028733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01882464277618409,"score_gpt":0.2942130348534588,"score_spread":0.2753883920772747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}